Given that, this present study provides an in-depth discussion of the important impact of miR-141-3p, an upstream regulator of Keap1-Nrf2 signaling pathway, on paclitaxel resistance in breast cancer cells. The gene discussed is NFE2L2; the disease is breast cancer.